Health

Colibactin toxin linked to rise in early-onset bowel cancer

Researchers suspect a bacterial toxin called colibactin drives the doubling of early-onset bowel cancer cases seen over the last two decades. This toxin produces mutations that appear three times more frequently in tumours from people under 40 than in those from people over 70.

Colibactin toxin linked to rise in early-onset bowel cancer

The toxin and early-onset cancer

Early-onset bowel cancer cases doubled in many countries over the past two decades. While obesity and low physical activity contribute, researchers suspect a bacterial toxin called colibactin drives this increase. This toxin, produced by certain E. coli variants, causes hallmark mutations that appear three times more frequently in tumours from people under 40 than in those from people over 70. Bowel cancer accounts for about one in 10 cases globally and is the third most common cancer. The disease is still far more common in people over 50, but global figures show diagnoses are rising steeply in younger people. Prof. Elio Riboli of Imperial College London told the committee that colibactin exists in people born after 1960. He said a mutation in the E. coli bacteria resulted in a "new bacteria."

Mutations and known risks

I find the gap between known risks and actual diagnoses problematic. Dr. Karl Smith-Byrne, a senior molecular epidemiologist at the University of Oxford, told the Commons science and technology committee that known risk factors like obesity, smoking, and alcohol can explain only about half of the cases doctors diagnose. He said he did not find it "plausible" that known risk factors could entirely explain the rise in early onset bowel cancer. Prof. Helen Coleman of Queen’s University Belfast called colibactin "the first new clue that we’ve had in quite some time," but she noted that the potential role of the toxin in bowel cancer remains under investigation. She noted that exposure could happen in very early childhood or even during the prenatal period.

Prof. Mike Stratton at the Sanger Institute said colibactin causes mutations in some children but not others. His work showed evidence of mutations appearing as early as infancy. By the age of 10, these affected children can have a "mutational burden" similar to a 50-year-old. Smith-Byrne, who survived early-onset rectal cancer, said that if colibactin causes mutations at a sensitive period, it gives the colon or rectum a "head start on its journey towards being cancerous or developing these tumours." Riboli noted that while obesity rises and physical activity declines, people could prevent about 60% of cancers by applying what they already know. In the UK and US, drinking and smoking are both falling.